Literature DB >> 2535913

CD30(Ki-1) antigen expression in a subset of gastric mucosal plasma cells and in a primary gastric plasmacytoma.

P Möller1, D U Matthaei-Maurer, G Moldenhauer.   

Abstract

With the use of frozen sections, 24 different monoclonal antibodies (MoAbs), and an indirect peroxidase technique, the antigenic profile of a well-differentiated primary gastric plasmacytoma was obtained. Corresponding to the normal plasma cell, tumor cells were devoid of HLA-D products and B-cell-restricted differentiation antigens CD19, CD20, CD21, CD22, and CD23 while expressing plasma cell-associated CD24 and CD38 molecules and IgA/lambda. The plasmacytoma furthermore reacted with CD30(Ki-1), a reactivity that for this tumor type has not been reported before. Subsequently, normal gastric mucosae affected by all degrees of chronic gastritis were examined. On the basis of serial sections, 5-15% of CD38(OKT10) reactive mucosal plasma cells were observed to also react with CD30(Ki-1). The authors conclude that the CD30 antigen is not only an activation antigen but is also expressed on a subset of terminally differentiated plasma cells.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2535913     DOI: 10.1093/ajcp/91.1.18

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  5 in total

1.  Monocytoid B cell lymphoma.

Authors:  S S Banerjee; M Harris; B P Eyden; J A Radford; C J Harrison; A R Mainwaring
Journal:  J Clin Pathol       Date:  1991-01       Impact factor: 3.411

2.  Induction of an autoimmune response against syngeneic lymphoma cells by immunogenic 64-kDa protein isolated from normal blast cells of BALB/c mice.

Authors:  R Stock; D Naor
Journal:  Cancer Immunol Immunother       Date:  1995-01       Impact factor: 6.968

3.  High expression of the CD30 molecule in human decidual cells.

Authors:  K Ito; T Watanabe; R Horie; M Shiota; S Kawamura; S Mori
Journal:  Am J Pathol       Date:  1994-08       Impact factor: 4.307

4.  Postoperative active specific immunization in curatively resected colorectal cancer patients with a virus-modified autologous tumor cell vaccine.

Authors:  B Lehner; P Schlag; W Liebrich; V Schirrmacher
Journal:  Cancer Immunol Immunother       Date:  1990       Impact factor: 6.968

5.  CD30-targeted therapy induces apoptosis of inflammatory cytokine-stimulated synovial fibroblasts and ameliorates collagen antibody-induced arthritis in mice.

Authors:  Minami Matsuhashi; Keiichiro Nishida; Misa Sakamoto; Yuka Gion; Aki Yoshida; Takayuki Katsuyama; Ryuichi Nakahara; Yoshihisa Nasu; Yoshinori Matsumoto; Yasuharu Sato; Toshifumi Ozaki
Journal:  Inflamm Res       Date:  2022-01-22       Impact factor: 4.575

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.